Structures, functions and adaptations of the human LINE-1 ORF2 protein

被引:0
|
作者
Eric T. Baldwin
Trevor van Eeuwen
David Hoyos
Arthur Zalevsky
Egor P. Tchesnokov
Roberto Sánchez
Bryant D. Miller
Luciano H. Di Stefano
Francesc Xavier Ruiz
Matthew Hancock
Esin Işik
Carlos Mendez-Dorantes
Thomas Walpole
Charles Nichols
Paul Wan
Kirsi Riento
Rowan Halls-Kass
Martin Augustin
Alfred Lammens
Anja Jestel
Paula Upla
Kera Xibinaku
Samantha Congreve
Maximiliaan Hennink
Kacper B. Rogala
Anna M. Schneider
Jennifer E. Fairman
Shawn M. Christensen
Brian Desrosiers
Gregory S. Bisacchi
Oliver L. Saunders
Nafeeza Hafeez
Wenyan Miao
Rosana Kapeller
Dennis M. Zaller
Andrej Sali
Oliver Weichenrieder
Kathleen H. Burns
Matthias Götte
Michael P. Rout
Eddy Arnold
Benjamin D. Greenbaum
Donna L. Romero
John LaCava
Martin S. Taylor
机构
[1] ROME Therapeutics,Laboratory of Cellular and Structural Biology
[2] The Rockefeller University,Computational Oncology, Department of Epidemiology & Biostatistics
[3] Memorial Sloan Kettering Cancer Center,Department of Pharmaceutical Chemistry
[4] Department of Bioengineering and Therapeutic Sciences University of California,Quantitative Biology Institute
[5] San Francisco,Department of Medical Microbiology and Immunology
[6] University of California,Department of Pathology
[7] San Francisco,European Research Institute for the Biology of Ageing
[8] University of California,Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology
[9] San Francisco,Charles River Laboratories
[10] University of Alberta,Department of Structural Biology
[11] Dana Farber Cancer Institute and Harvard Medical School,Department of Chemical and Systems Biology
[12] University Medical Center Groningen,Stanford Cancer Institute
[13] Rutgers University,Structural Biology of Selfish RNA, Department of Protein Evolution
[14] Chesterford Research Park,Department of Biology
[15] Proteros Biostructures GmbH,Physiology, Biophysics & Systems Biology, Weill Cornell Medicine
[16] Martinsried,Department of Pathology
[17] Whitehead Institute for Biomedical Research,undefined
[18] Stanford University School of Medicine,undefined
[19] Stanford University School of Medicine,undefined
[20] Stanford University School of Medicine,undefined
[21] Max Planck Institute for Biology,undefined
[22] Johns Hopkins University School of Medicine,undefined
[23] University of Texas at Arlington,undefined
[24] Weill Cornell Medical College,undefined
[25] Massachusetts General Hospital and Harvard Medical School,undefined
来源
Nature | 2024年 / 626卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The LINE-1 (L1) retrotransposon is an ancient genetic parasite that has written around one-third of the human genome through a ‘copy and paste’ mechanism catalysed by its multifunctional enzyme, open reading frame 2 protein (ORF2p)1. ORF2p reverse transcriptase (RT) and endonuclease activities have been implicated in the pathophysiology of cancer2,3, autoimmunity4,5 and ageing6,7, making ORF2p a potential therapeutic target. However, a lack of structural and mechanistic knowledge has hampered efforts to rationally exploit it. We report structures of the human ORF2p ‘core’ (residues 238–1061, including the RT domain) by X-ray crystallography and cryo-electron microscopy in several conformational states. Our analyses identified two previously undescribed folded domains, extensive contacts to RNA templates and associated adaptations that contribute to unique aspects of the L1 replication cycle. Computed integrative structural models of full-length ORF2p show a dynamic closed-ring conformation that appears to open during retrotransposition. We characterize ORF2p RT inhibition and reveal its underlying structural basis. Imaging and biochemistry show that non-canonical cytosolic ORF2p RT activity can produce RNA:DNA hybrids, activating innate immune signalling through cGAS/STING and resulting in interferon production6–8. In contrast to retroviral RTs, L1 RT is efficiently primed by short RNAs and hairpins, which probably explains cytosolic priming. Other biochemical activities including processivity, DNA-directed polymerization, non-templated base addition and template switching together allow us to propose a revised L1 insertion model. Finally, our evolutionary analysis demonstrates structural conservation between ORF2p and other RNA- and DNA-dependent polymerases. We therefore provide key mechanistic insights into L1 polymerization and insertion, shed light on the evolutionary history of L1 and enable rational drug development targeting L1.
引用
收藏
页码:194 / 206
页数:12
相关论文
共 50 条
  • [1] Structures, functions and adaptations of the human LINE-1 ORF2 protein
    Baldwin, Eric T.
    van Eeuwen, Trevor
    Hoyos, David
    Zalevsky, Arthur
    Tchesnokov, Egor P.
    Sanchez, Roberto
    Miller, Bryant D.
    Di Stefano, Luciano H.
    Ruiz, Francesc Xavier
    Hancock, Matthew
    Isik, Esin
    Mendez-Dorantes, Carlos
    Walpole, Thomas
    Nichols, Charles
    Wan, Paul
    Riento, Kirsi
    Halls-Kass, Rowan
    Augustin, Martin
    Lammens, Alfred
    Jestel, Anja
    Upla, Paula
    Xibinaku, Kera
    Congreve, Samantha
    Hennink, Maximiliaan
    Rogala, Kacper B.
    Schneider, Anna M.
    Fairman, Jennifer E.
    Christensen, Shawn M.
    Desrosiers, Brian
    Bisacchi, Gregory S.
    Saunders, Oliver L.
    Hafeez, Nafeeza
    Miao, Wenyan
    Kapeller, Rosana
    Zaller, Dennis M.
    Sali, Andrej
    Weichenrieder, Oliver
    Burns, Kathleen H.
    Goette, Matthias
    Rout, Michael P.
    Arnold, Eddy
    Greenbaum, Benjamin D.
    Romero, Donna L.
    Lacava, John
    Taylor, Martin S.
    NATURE, 2024, 626 (7997) : 194 - 206
  • [2] Development of a monoclonal antibody specific to the endonuclease domain of the human LINE-1 ORF2 protein
    Sokolowski, Mark
    DeFreece, Cecily B.
    Servant, Geraldine
    Kines, Kristine J.
    deHaro, Dawn L.
    Belancio, Victoria P.
    MOBILE DNA, 2014, 5
  • [3] Development of a monoclonal antibody specific to the endonuclease domain of the human LINE-1 ORF2 protein
    Mark Sokolowski
    Cecily B DeFreece
    Geraldine Servant
    Kristine J Kines
    Dawn L deHaro
    Victoria P Belancio
    Mobile DNA, 5
  • [4] The carboxy-terminal segment of the human LINE-1 ORF2 protein is involved in RNA binding
    Piskareva, Olga
    Ernst, Christina
    Higgins, Niamh
    Schmatchenko, Vadim
    FEBS OPEN BIO, 2013, 3 : 433 - 437
  • [5] The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations
    Kristine J. Kines
    Mark Sokolowski
    Dawn L. deHaro
    Claiborne M. Christian
    Melody Baddoo
    Madison E. Smither
    Victoria P. Belancio
    Mobile DNA, 7
  • [6] The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations
    Kines, Kristine J.
    Sokolowski, Mark
    deHaro, Dawn L.
    Christian, Claiborne M.
    Baddoo, Melody
    Smither, Madison E.
    Belancio, Victoria P.
    MOBILE DNA, 2016, 7
  • [7] A re-evaluation of LINE-1 ORF2 expression in LNCaP prostate cancer cells
    Briggs, Erica M.
    Spadafora, Corrado
    Logan, Susan K.
    MOBILE DNA, 2019, 10 (01)
  • [8] A re-evaluation of LINE-1 ORF2 expression in LNCaP prostate cancer cells
    Erica M. Briggs
    Corrado Spadafora
    Susan K. Logan
    Mobile DNA, 10
  • [9] AUG-independent translation of human LINE-1 ORF2.
    Alisch, RS
    Garcia-Perez, J
    Moran, JV
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 354 - 354
  • [10] LINE-1 ORF2p expression is nearly imperceptible in human cancers
    Daniel Ardeljan
    Xuya Wang
    Mehrnoosh Oghbaie
    Martin S. Taylor
    David Husband
    Vikram Deshpande
    Jared P. Steranka
    Mikhail Gorbounov
    Wan Rou Yang
    Brandon Sie
    H. Benjamin Larman
    Hua Jiang
    Kelly R. Molloy
    Ilya Altukhov
    Zhi Li
    Wilson McKerrow
    David Fenyö
    Kathleen H. Burns
    John LaCava
    Mobile DNA, 11